Thursday, August 6, 2026

HomeHealth NewsAdvancing patient-reported outcomes in cancer clinical trials

Advancing patient-reported outcomes in cancer clinical trials

- Advertisement -

Credit: Unsplash/CC0 Public Domain

The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how its recommendations for patient-reported outcomes (PROs) in cancer clinical trials were developed.

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed